Fieldpoint Private Securities, LLC Biomarin Pharmaceutical Inc Transaction History

Fieldpoint Private Securities, LLC

$344 Million
Q2 2022

A detailed history of Fieldpoint Private Securities, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 1,155 shares of BMRN stock, worth $81,519. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,155

Previous 1,158 0.26%

Holding current value

$81,519

Previous $89,000 7.87%

% of portfolio

0.03%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$71.48 - $86.85 $214 - $260	-3 Reduced 0.26%	1,155 $96,000
Q1 2022 Apr 07, 2022	BUY	$74.28 - $92.69 $86,016 - $107,335	1,158 New	1,158 $89,000
Q3 2021 Nov 12, 2021	SELL	$74.77 - $85.47 $121,650 - $139,059	-1,627 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $20,236 - $22,723	-268 Reduced 14.14%	1,627 $125,000
Q1 2021 Apr 23, 2021	SELL	$74.73 - $90.69 $39,382 - $47,793	-527 Reduced 21.76%	1,895 $143,000
Q4 2020 Jan 28, 2021	SELL	$72.61 - $90.2 $26,793 - $33,283	-369 Reduced 13.22%	2,422 $212,000
Q3 2020 Oct 23, 2020	BUY	$71.87 - $131.03 $51,458 - $93,817	716 Added 34.51%	2,791 $212,000
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $229,501 - $358,374	-2,885 Reduced 58.17%	2,075 $256,000
Q1 2020 May 11, 2020	BUY	$71.37 - $96.85 $16,557 - $22,469	232 Added 4.91%	4,960 $419,000
Q4 2019 Feb 10, 2020	BUY	$64.27 - $86.37 $92,227 - $123,940	1,435 Added 43.58%	4,728 $400,000
Q3 2019 Nov 07, 2019	BUY	$67.4 - $85.11 $60,660 - $76,599	900 Added 37.61%	3,293 $222,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $24,506 - $28,639	-305 Reduced 11.3%	2,393 $205,000
Q1 2019 May 13, 2019	SELL	$84.2 - $98.62 $23,576 - $27,613	-280 Reduced 9.4%	2,698 $240,000
Q4 2018 Feb 11, 2019	BUY	$80.14 - $106.07 $238,656 - $315,876	2,978 New	2,978 $254,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.

Account

Fieldpoint Private Securities, LLC Biomarin Pharmaceutical Inc Transaction History